The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a ...

Three fatalities occurring recently in China clinical trials have spurred two members of U.S. Congress to urge the FDA to ...

After committing $2 billion to a new North Carolina facility to boost capacity for its next-gen obesity candidates, Roche's ...

The accelerated greenlight for Ultragenyx’s gene therapy for glycogen storage disease has raised analyst expectations for ...

Regeneron’s Pasatru is the second fibrodysplasia ossificans progressiva drug approved in the U.S., following the 2023 ...

Workforce cuts this year at seven companies involved in recent mergers and acquisitions will cost over 1,300 employees their ...

If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA ...

Melanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the ...

Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering ...

Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so ...

If Heidi Overton clears the Senate nomination process, analysts say she will have a tough job ahead to “restore ...

Biopharma professionals can find themselves out of jobs when employers want to bring staff back into the office, as recently ...